Th2 allergic immune response to inhaled fungal antigens is modulated by TLR‐4‐independent bacterial products
暂无分享,去创建一个
S. Akira | D. Hogan | M. Wargo | S. Uematsu | M. Rincón | M. Poynter | L. Whittaker | J. Allard | G. Allen | L. Rinaldi
[1] H. Bibi,et al. Impact of specific allergen sensitization on the prevalence of asthma in patients with allergic rhinitis from adjacent distinct geographic areas. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[2] E. Trafny,et al. Diverse type III secretion phenotypes among Pseudomonas aeruginosa strains upon infection of murine macrophage-like and endothelial cell lines. , 2008, Microbial pathogenesis.
[3] D. Reinhardt,et al. Efficacy and safety of intravenous meropenem and tobramycin versus ceftazidime and tobramycin in cystic fibrosis. , 2008, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.
[4] Michelle D. Brazas,et al. Swarming of Pseudomonas aeruginosa Is a Complex Adaptation Leading to Increased Production of Virulence Factors and Antibiotic Resistance , 2008, Journal of bacteriology.
[5] J. Portnoy,et al. Importance of mold allergy in asthma , 2008, Current allergy and asthma reports.
[6] S. Kunkel,et al. Toll-like receptors, Notch ligands, and cytokines drive the chronicity of lung inflammation. , 2007, Proceedings of the American Thoracic Society.
[7] E. Pamer. Immune responses to commensal and environmental microbes , 2007, Nature Immunology.
[8] R. Ulevitch,et al. TLR4/MD-2 Monoclonal Antibody Therapy Affords Protection in Experimental Models of Septic Shock , 2007, The Journal of Immunology.
[9] G. Pier. Pseudomonas aeruginosa lipopolysaccharide: a major virulence factor, initiator of inflammation and target for effective immunity. , 2007, International journal of medical microbiology : IJMM.
[10] T. Murphy,et al. Infections in Chronic Lung Diseases , 2007, Infectious Disease Clinics of North America.
[11] J. Wedzicha,et al. The biology of a chronic obstructive pulmonary disease exacerbation. , 2007, Clinics in chest medicine.
[12] D. Hassett,et al. Pseudomonas aeruginosa AlgR Represses the Rhl Quorum-Sensing System in a Biofilm-Specific Manner , 2007, Journal of bacteriology.
[13] D. Corry,et al. A new mechanism regulating the initiation of allergic airway inflammation. , 2007, The Journal of allergy and clinical immunology.
[14] S. Bauer,et al. Immunobiology of toll-like receptors in allergic disease. , 2007, Immunobiology.
[15] T. Colby,et al. Coexpression of IL-5 and Eotaxin-2 in Mice Creates an Eosinophil-Dependent Model of Respiratory Inflammation with Characteristics of Severe Asthma1 , 2007, The Journal of Immunology.
[16] B. Celli,et al. Exacerbations of chronic obstructive pulmonary disease , 2007, European Respiratory Journal.
[17] A. Prince,et al. Opportunistic infections in lung disease: Pseudomonas infections in cystic fibrosis. , 2007, Current opinion in pharmacology.
[18] M. Whyte,et al. Reducing the toll of inflammatory lung disease. , 2007, Chest.
[19] Y. Gho,et al. Airway Exposure Levels of Lipopolysaccharide Determine Type 1 versus Type 2 Experimental Asthma1 , 2007, The Journal of Immunology.
[20] R. Kronmal,et al. Association between pulmonary function and sputum biomarkers in cystic fibrosis. , 2007, American journal of respiratory and critical care medicine.
[21] S. Atiş,et al. Relationship between airway colonization, inflammation and exacerbation frequency in COPD. , 2007, Respiratory medicine.
[22] Freya Harrison,et al. Microbial ecology of the cystic fibrosis lung. , 2007, Microbiology.
[23] K. Marr,et al. Aspergillus fumigatus Generates an Enhanced Th2-Biased Immune Response in Mice with Defective Cystic Fibrosis Transmembrane Conductance Regulator1 , 2006, The Journal of Immunology.
[24] E. Pamer,et al. Innate immune activation and CD4+ T cell priming during respiratory fungal infection. , 2006, Immunity.
[25] S. Johnston,et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. , 2006, American journal of respiratory and critical care medicine.
[26] T. Nikaido,et al. Relationship between Calcium-Activated Chloride Channel 1 and MUC5AC in Goblet Cell Hyperplasia Induced by Interleukin-13 in Human Bronchial Epithelial Cells , 2006, Respiration.
[27] S. Sethi,et al. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.
[28] D. Underhill,et al. Dectin-1 and TLRs Permit Macrophages to Distinguish between Different Aspergillus fumigatus Cellular States1 , 2006, The Journal of Immunology.
[29] D. Chaplin,et al. 1. Overview of the human immune response. , 2006, The Journal of allergy and clinical immunology.
[30] C. Bachert,et al. The Innate Immune System and Its Role in Allergic Disorders , 2006, International Archives of Allergy and Immunology.
[31] T. Hohl,et al. Distinct CD4+-T-Cell Responses to Live and Heat-Inactivated Aspergillus fumigatus Conidia , 2005, Infection and Immunity.
[32] T. Hohl,et al. Aspergillus fumigatus Triggers Inflammatory Responses by Stage-Specific β-Glucan Display , 2005, PLoS pathogens.
[33] L. Saiman,et al. The efficacy and safety of meropenem and tobramycin vs ceftazidime and tobramycin in the treatment of acute pulmonary exacerbations in patients with cystic fibrosis. , 2005, Chest.
[34] J. Shellito,et al. Divergent roles of IL-23 and IL-12 in host defense against Klebsiella pneumoniae , 2005, The Journal of experimental medicine.
[35] R. Glenny,et al. Modulation of Lipopolysaccharide-Induced Gene Transcription and Promotion of Lung Injury by Mechanical Ventilation1 , 2005, The Journal of Immunology.
[36] N. McElvaney,et al. Toll-like receptor expression and function in airway epithelial cells. , 2005, Archivum immunologiae et therapiae experimentalis.
[37] N. Ritz,et al. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis , 2005, European Journal of Pediatrics.
[38] M. Kosorok,et al. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.
[39] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[40] R. Kolter,et al. A Pseudomonas aeruginosa quorum‐sensing molecule influences Candida albicans morphology , 2004, Molecular microbiology.
[41] A. Lindén,et al. Interleukin-17 family members and inflammation. , 2004, Immunity.
[42] A. Prince,et al. TLR2 is mobilized into an apical lipid raft receptor complex to signal infection in airway epithelial cells. , 2004, The Journal of clinical investigation.
[43] A. Prince,et al. Pseudomonas aeruginosa flagella activate airway epithelial cells through asialoGM1 and toll-like receptor 2 as well as toll-like receptor 5. , 2004, American journal of respiratory cell and molecular biology.
[44] B. Vargaftig,et al. Bacterial Lipopolysaccharide Signaling Through Toll-Like Receptor 4 Suppresses Asthma-Like Responses Via Nitric Oxide Synthase 2 Activity1 , 2003, The Journal of Immunology.
[45] D. Hess,et al. Effect of lipopolysaccharide on virulence of intestinal candida albicans. , 2003, The Journal of surgical research.
[46] C. Irvin,et al. A Prominent Role for Airway Epithelial NF-κB Activation in Lipopolysaccharide-Induced Airway Inflammation1 , 2003, The Journal of Immunology.
[47] James J. Lee,et al. A causative relationship exists between eosinophils and the development of allergic pulmonary pathologies , 2003 .
[48] Kim Bottomly,et al. Lipopolysaccharide-enhanced, Toll-like Receptor 4–dependent T Helper Cell Type 2 Responses to Inhaled Antigen , 2002, The Journal of experimental medicine.
[49] R. Stevens. Faculty Opinions recommendation of A protease-activated pathway underlying Th cell type 2 activation and allergic lung disease. , 2002 .
[50] F. Accurso,et al. Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis. , 2002, The Journal of pediatrics.
[51] J. Bates,et al. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. , 2002, Journal of applied physiology.
[52] B. Afessa,et al. Prognostic factors, clinical course, and hospital outcome of patients with chronic obstructive pulmonary disease admitted to an intensive care unit for acute respiratory failure , 2002, Critical care medicine.
[53] R. Kolter,et al. Pseudomonas-Candida Interactions: An Ecological Role for Virulence Factors , 2002, Science.
[54] B. Strandvik,et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF , 2001 .
[55] K. Wright,et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.
[56] G. Cieslewicz,et al. The late, but not early, asthmatic response is dependent on IL-5 and correlates with eosinophil infiltration. , 1999, The Journal of clinical investigation.
[57] R. Homer,et al. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils. , 1999, Journal of immunology.
[58] P. Gacesa. Bacterial alginate biosynthesis--recent progress and future prospects. , 1998, Microbiology.
[59] F. Ausubel,et al. Common virulence factors for bacterial pathogenicity in plants and animals. , 1995, Science.
[60] G. Akagawa,et al. Mortality of Candida albicans-infected mice is facilitated by superinfection of Escherichia coli or administration of its lipopolysaccharide. , 1995, The Journal of infectious diseases.
[61] V. Kurup,et al. Immune responses to Aspergillus fumigatus and Pseudomonas aeruginosa antigens in cystic fibrosis and allergic bronchopulmonary aspergillosis. , 1994, Chest.
[62] D. Irwin,et al. Isogenic strain construction and gene mapping in Candida albicans. , 1993, Genetics.
[63] G. Doern,et al. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis , 1992, Journal of clinical microbiology.
[64] C. S. Raymond,et al. Endotoxin promotes synergistic lethality during concurrent Escherichia coli and Candida albicans infection. , 1992, The Journal of surgical research.
[65] A. Kharazmi,et al. Mechanisms involved in the evasion of the host defence by Pseudomonas aeruginosa. , 1991, Immunology letters.
[66] K. A. Wall,et al. Characterization of the murine T cell surface molecule, designated L3T4, identified by monoclonal antibody GK1.5: similarity of L3T4 to the human Leu-3/T4 molecule. , 1983, Journal of immunology.
[67] K. Botzenhart,et al. Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis. , 1983, The Journal of infectious diseases.
[68] M. Netea,et al. An integrated model of the recognition of Candida albicans by the innate immune system , 2008, Nature Reviews Microbiology.
[69] S. Akira,et al. Dectin-1 is required for host defense against Pneumocystis carinii but not against Candida albicans , 2007, Nature Immunology.
[70] S. Gordon,et al. Dectin-1 is required for beta-glucan recognition and control of fungal infection. , 2007, Nature immunology.
[71] S. Gordon,et al. Dectin-1 is required for β-glucan recognition and control of fungal infection , 2007, Nature Immunology.
[72] David D. Chaplin,et al. Overview of the human immune response , 2006 .
[73] H. Renz,et al. The immunological basis of the hygiene hypothesis. , 2006, Chemical immunology and allergy.
[74] N. Ritz,et al. Risk factors for allergic bronchopulmonary aspergillosis and sensitisation to Aspergillus fumigatus in patients with cystic fibrosis , 2006, European Journal of Pediatrics.
[75] R. Moss. Pathophysiology and immunology of allergic bronchopulmonary aspergillosis. , 2005, Medical mycology.
[76] Samuel I. Miller,et al. LPS, TLR4 and infectious disease diversity , 2005, Nature Reviews Microbiology.
[77] M. Berger. Inflammatory mediators in cystic fibrosis lung disease. , 2002, Allergy and asthma proceedings.
[78] M. Delos,et al. Chronic obstructive pulmonary disease patients with invasive pulmonary aspergillosis: benefits of intensive care? , 2001, Intensive Care Medicine.
[79] B. Strandvik,et al. Factors associated with poor pulmonary function: cross-sectional analysis of data from the ERCF. European Epidemiologic Registry of Cystic Fibrosis. , 2001, The European respiratory journal.
[80] J. Fredberg,et al. Input impedance and peripheral inhomogeneity of dog lungs. , 1992, Journal of applied physiology.
[81] B. Jones. Evidence that the Thy‐1 molecule is the target for T cell mitogenic antibody against brain‐associated antigens , 1983, European journal of immunology.